Pfizer tracks vaccine safety in korea after approval
NCT ID NCT06613984
Summary
This study is monitoring the safety of the approved Pfizer COVID-19 vaccine (Comirnaty) in real-world use in Korea. It involves 660 Korean people who are getting the vaccine as part of their normal medical care. The main goal is to collect information on any side effects that occur after vaccination to better understand the vaccine's safety profile.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 VACCINATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pfizer
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.